Daniela Cajado-Carvalho, Specialist of Production at Butantan Institute, BioIndustrial Division, Aerobic Vaccines Sector, from March 2021 to date. Undergraduate degree in Biological Sciences
(Bachelor's degree) from Mackenzie Presbyterian University (2010), Master's
degree in Science from the Disease Control Coordination–Public Health
Secretariat (2013), and PhD in Science from the Interunit in Biotechnology Program, University of São Paulo (2017), developing its activities at the Butantan
Institute. Postdoctorate carried out in the Applied Toxinology laboratory of
the Butantan Institute, working on the study of the action of the serine
protease PA-BJ on primary cultures of peripheral blood endothelial cells. She
has experience in the areas of biochemistry and cellular biology, especially
in the chemistry of proteins, peptides, and enzymes from animal venoms
(characterization and purification). She is currently working with analysis of
vaccine particles and other immunobiological products (in-process control) and
downstream processing of bacterial vaccines.
Daniela Cajado-Carvalho, Specialist of Production at Butantan Institute, BioIndustrial Division, Aerobic Vaccines Sector, from March 2021 to date. Undergraduate degree in Biological Sciences
(Bachelor's degree) from Mackenzie Presbyterian University (2010), Master's
degree in Science from the Disease Control Coordination–Public Health
Secretariat (2013), and PhD in Science from the Interunit in Biotechnology Program, University of São Paulo (2017), developing its activities at the Butantan
Institute. Postdoctorate carried out in the Applied Toxinology laboratory of
the Butantan Institute, working on the study of the action of the serine
protease PA-BJ on primary cultures of peripheral blood endothelial cells. She
has experience in the areas of biochemistry and cellular biology, especially
in the chemistry of proteins, peptides, and enzymes from animal venoms
(characterization and purification). She is currently working with analysis of
vaccine particles and other immunobiological products (in-process control) and
downstream processing of bacterial vaccines.